IP Library Granted Patent US 10,653,615
Granted Patent B2
US 10,653,615 · App. 16/030,485 · Granted May 19, 2020

Use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositions

Inventors: Andre P. Boulet (Quebec, CA); Paul Maes (Chatillon, BE)
A61K8/97A61K8/99A61K36/00A61Q17/04A61Q19/004A61Q19/08A61K2800/522
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,615
App. No.
16/030,485
Granted
May 19, 2020
Kind
B2
Abstract

The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.

Claims (9)

1. A method for increasing hydration or elasticity of a dry skin comprising applying to the dry skin an effective amount of a cosmetic composition comprising: a functional thylakoids-containing photosynthetic cell extract (PCE), and a topically-acceptable carrier, wherein the PCE is present in an amount from about 0.01% to about 0.1% based upon the total weight of the composition, wherein the dry skin is free from disease.

2. The method of claim 1 , wherein the carrier is selected from the group consisting of fats, hydrophilic or lipophilic gelling agents, and fillers.

3. The method of claim 1 , wherein the extract is non-lyophilized and formulated in a liquid composition.

4. The method of claim 1 , wherein the extract is a lyophilized extract reconstituted in a solution compatible with topical administration.

5. The method of claim 2 , wherein the carrier is a fat selected from the group consisting of: emulsifiers and coemulsifiers.

6. The method of claim 2 , wherein the composition further comprises a preservative agent.

7. The method of claim 4 , wherein the lyophilized extract is reconstituted in water, physiological saline or propylene glycol.

8. The method of claim 4 , wherein the lyophilized extract is in a solid composition.

9. A method for increasing hydration or elasticity of a dry skin comprising applying to the dry skin an effective amount of a cosmetic composition consisting essentially of: a functional thylakoids-containing photosynthetic cell extract (PCE), and a topically-acceptable carrier, wherein the PCE is present in an amount from about 0.01% to about 0.1% based upon the total weight of the composition, wherein the dry skin is free of a condition.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2026
From: FIERA PRIVATE DEBT INC.
To: GROUPE SANTE DEVONIAN INC.
Reel/Frame 074163/0489 →
SECURITY INTEREST Recorded Feb 23, 2024
From: DEVONIAN HEALTH GROUP INC.
To: FIERA PRIVATE DEBT INC.
Reel/Frame 066539/0690 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2024
From: GRX HEALTHCARE INC.
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 066287/0652 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 16154364 PREVIOUSLY RECORDED AT REEL: 048359 FRAME: 0174. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 28, 2021
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 057292/0433 →
SECURITY INTEREST Recorded Feb 18, 2019
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 048359/0174 →